dc.creator | Amaral, Eliana | |
dc.creator | Perdigao, Antero | |
dc.creator | Souza, Maria Helena | |
dc.creator | Mauck, Christine | |
dc.creator | Waller, Donald | |
dc.creator | Zaneveld, Lourens | |
dc.creator | Faundes, Anibal | |
dc.date | 2006-May | |
dc.date | 2015-11-27T13:05:22Z | |
dc.date | 2015-11-27T13:05:22Z | |
dc.date.accessioned | 2018-03-29T01:02:40Z | |
dc.date.available | 2018-03-29T01:02:40Z | |
dc.identifier | Contraception. v. 73, n. 5, p. 542-7, 2006-May. | |
dc.identifier | 0010-7824 | |
dc.identifier | 10.1016/j.contraception.2005.12.006 | |
dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/16627043 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/196731 | |
dc.identifier | 16627043 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1296964 | |
dc.description | ACIDFORM is a microbicidal and contraceptive candidate with strong buffering capacity. This was a Phase I blinded, randomized and crossover clinical study on two products, ACIDFORM and a commercial nonoxynol-9 (N-9) product (2%), evaluating their vaginal safety in 20 couples aged between 19 and 45 years. The women had regular menses, underwent previous tubal ligation, were not breast-feeding, had no vaginal sign and symptom and were in a stable partnership; both partners had no previous STI. Colposcopy, vaginal microbiology, inflammation markers and subject complaints were studied after coitus. Women were randomly assigned sequentially to receive ACIDFORM 0-30 min (0-30 min before intercourse), ACIDFORM 8-10 h (8-10 h before intercourse) or N-9 0-30 min after a control cycle. Mild/moderate vulvar irritation was observed in five postcoital test colposcopies, burning and pruritus were reported in six treated cycles and non-irritation-related symptoms were found in five cycles with different treatments. No difference in vaginal pH, Nugent scores, H2O2-producing lactobacillus or leukocytes and interleukin 6 in the cervicovaginal lavage was found between the treatment and control cycles. ACIDFORM appears to be safe for clinical use once a day. There is a potential spermicidal-microbicidal role for ACIDFORM as a vaginal flora helper or as a vehicle for products, except N-9. | |
dc.description | 73 | |
dc.description | 542-7 | |
dc.language | eng | |
dc.relation | Contraception | |
dc.relation | Contraception | |
dc.rights | fechado | |
dc.rights | | |
dc.source | PubMed | |
dc.subject | Adult | |
dc.subject | Anti-infective Agents, Local | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Hydrogen-ion Concentration | |
dc.subject | Male | |
dc.subject | Nonoxynol | |
dc.subject | Spermatocidal Agents | |
dc.subject | Vagina | |
dc.title | Vaginal Safety After Use Of A Bioadhesive, Acid-buffering, Microbicidal Contraceptive Gel (acidform) And A 2% Nonoxynol-9 Product. | |
dc.type | Artículos de revistas | |